Deals
Smith & Nephew to Buy ArthroCare for $1.7 Billion in Cash
This article is for subscribers only.
Smith & Nephew Plc agreed to buy ArthroCare Corp. for $1.7 billion in cash to add products for minimally invasive surgery used in sports medicine.
ArthroCare holders will receive $48.25 a share in cash, London-based Smith & Nephew said in a statement today. The price is 6.3 percent more than the Austin, Texas-based company’s closing level Jan. 31 in Nasdaq trading. ArthroCare rose above the takeover price, indicating some investors may be speculating on a higher offer.